drugset / Trial / NCT02327936
Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to evaluate the tolerability of Fesoterodine and Oxytbutynin XL and to compare their efficacy for overactive bladder syndrome in children.
Timeline
- Start
- 2014-12
- Primary completion
- 2018-03
- Completion
- 2018-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | Oral |
| Subject | Fesoterodine | Other / unclassified | 8 mg | Oral |
| Comparator | Oxybutynin XL | Unknown | 10 mg | Oral |
| Comparator | Oxybutynin XL | Unknown | 20 mg | Oral |